EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Multizentrische Studie

Phase 2b Trial of a Na V 1.8 Inhibitor for Acute Pain

Neil Singla iD, Nathaniel P Katz, Ben Vaughn, Timothy Rogier, Todd Bertoch, Harold Minkowitz, Mallory Loflin

New England Journal of Medicine · 2026

DOI: 10.1056/nejmoa2602910 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, 2026. Verfasst von Neil Singla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Latigo Biotherapeutics, Thousand Oaks, CA. Hauptthemen laut MEDLINE: Acute Pain, NAV1.8 Voltage-Gated Sodium Channel, Postoperative Pain, Voltage-Gated Sodium Channel Blockers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute PainNAV1.8 Voltage-Gated Sodium ChannelPostoperative PainVoltage-Gated Sodium Channel BlockersAdultFemaleHumansMaleMiddle AgedAcetaminophenAnalgesics, OpioidDouble-Blind MethodDrug CombinationsHydrocodonePain MeasurementAbdominoplastyAnti-Inflammatory Agents, Non-SteroidalIncidenceDose-Response Relationship, DrugFeverSyncopeYoung AdultTreatment Outcome

Substanzen

Acetaminophenacetaminophen, hydrocodone drug combinationAnalgesics, OpioidDrug CombinationsHydrocodoneNAV1.8 Voltage-Gated Sodium ChannelVoltage-Gated Sodium Channel BlockersAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Latigo Biotherapeutics, Thousand Oaks, CA.
  • Ein Sof Innovation, Boston.
  • Vital Clinical Solutions, Boston.
  • CenExel, Salt Lake City.
  • Evolution Research Group Research, New Providence, NJ.
  • University of Texas M.D. Anderson Cancer Center, Houston.

ORCID-Profile: Neil Singla

Zitieren

APA

Singla, N., Katz, N. P., Vaughn, B., Rogier, T., Bertoch, T., Minkowitz, H., & Loflin, M. (2026). Phase 2b Trial of a Na V 1.8 Inhibitor for Acute Pain. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2602910

Vancouver

Singla N, Katz NP, Vaughn B, Rogier T, Bertoch T, Minkowitz H, et al. Phase 2b Trial of a Na V 1.8 Inhibitor for Acute Pain. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2602910

BibTeX
@article{Singla2026,
  author = {Singla, Neil and Katz, Nathaniel P and Vaughn, Ben and Rogier, Timothy and Bertoch, Todd and Minkowitz, Harold and Loflin, Mallory},
  title = {Phase 2b Trial of a Na V 1.8 Inhibitor for Acute Pain},
  journal = {New England Journal of Medicine},
  year = {2026},
  doi = {10.1056/nejmoa2602910}
}
Kostenlos starten →